ATHE Alterity Therapeutics Limited ADRs

Alterity, formerly Prana Biotechnology, Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:PBT.

$1.33  +0.02 (1.53%)
As of 10/18/2021 15:56:10 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  
IPO date:  04/09/2019
Outstanding shares:  40,114,576
Average volume:  301,572
Market cap:   $52,148,949
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    02155X106
ISIN:        US02155X1063
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.46
PS ratio:   0.00
Return on equity:   -45.57%
Net income %:   -29,943.85%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy